International Assets Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Buy
1,539
+700
+83% +$94.6K 0.01% 785
2026
Q1
$108K Sell
839
-9
-1% -$1.12K 0.01% 1000
2025
Q4
$103K Buy
+848
New +$97.2K 0.01% 1001
2024
Q3
Sell
-2,053
Closed -$190K 2656
2024
Q2
$190K Sell
2,053
-261
-11% -$23.4K 0.02% 733
2024
Q1
$217K Buy
+2,314
New +$215K 0.02% 648
2022
Q1
Sell
-10,134
Closed -$991K 596
2021
Q4
$991K Sell
10,134
-4,795
-32% -$578K 0.17% 138
2021
Q3
$1.27M Hold
14,929
0.23% 107
2021
Q2
$1.27M Buy
+14,929
New +$1.96M 0.24% 99
2020
Q3
Sell
-57,808
Closed -$3.07M 454
2020
Q2
$3.07M Buy
57,808
+30,398
+111% +$2.99M 0.73% 24
2020
Q1
$1.53M Buy
+27,410
New +$2.43M 0.47% 43

Other funds holding XBI

International Assets Investment Management's XBI Position: Q2 2026 in Review

International Assets Investment Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 83% in Q2 2026, buying an estimated $94.6K and bringing the position to 1,539 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #785.

International Assets Investment Management first reported a position in XBI in Q1 2020 and has held it in 10 quarters since. The position peaked at $3.07M in Q2 2020. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • International Assets Investment Management held 1,539 shares of State Street SPDR S&P Biotech ETF worth $241K as of Q2 2026.
  • International Assets Investment Management bought 700 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $94.6K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #785 holding.
  • International Assets Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 10 quarters since.
  • International Assets Investment Management's State Street SPDR S&P Biotech ETF position peaked at $3.07M in Q2 2020.
  • 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.